Search Results 771-780 of 18208 for Immunode

1. Novel Study Interventions and Combinations in Participants with Colorectal Cancer - Mayo Clinic

   Known history of immunodeficiency, or other acquired, congenital immunodeficiency disorders, or history of organ transplantation and allogeneic bone marrow ...

2. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Subject is known to have human immunodeficiency virus infection; Subject has active hepatitis B or C, or other active hepatic disorder. Participating Mayo ...

3. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Human immunodeficiency virus (HIV), hepatitis B, or hepatitis C viral screening test showing evidence of active or chronic viral infection at Screening or a ...

4. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Known prior history of human immunodeficiency virus (HIV); Administration of live vaccines =< 14 days prior to registration; note: patients may not receive ...

5. Ixazomib Citrate, Pomalidomide, Dexamethasone, and Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Negative human immunodeficiency virus (HIV), hepatitis B and C test. Willing to follow the requirements of the Pomalyst REMS program. Willing to return to ...

6. Vaccine Therapy and Resiquimod in Treating Patients with Stage II-IV Melanoma that has been Removed by Surgery - Mayo Clinic

   Known immune deficiency, including human immunodeficiency virus (HIV) infection, as patients with known immune deficiencies will likely not be able to mount ...

7. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

   Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive; Hypersensitivity to pegfilgrastim or Escherichia (E.) coli ...

8. A Study of Using Mesenchymal Stem Cells Developed from the Patients Own Fat Tissue for Reducing Hemodialysis Arteriovenous Fistula Failure - Mayo Clinic

   Immunodeficiency including AIDS / HIV or Active autoimmune disease. Documented hypercoagulable state or history of 2 or more DVTs or other spontaneous ...

9. Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris - Mayo Clinic

   Participation eligibility · Vulnerable study population · Pregnant or nursing women · Women planning a pregnancy within the study period · Human immunodeficiency ...

10. MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery - Mayo Clinic

    Known immune deficiency, including human immunodeficiency virus (HIV) infection; History of systemic autoimmune disease, as patients with ongoing ...